Alison Taunton-Rigby | Director & Trustee, Healthcare, Life Sciences and Financial Services

Alison Taunton-Rigby, Ph.D., O.B.E., is a well-known executive, leader and entrepreneur in the world of healthcare, life sciences and financial services. She has served as a Director on a number of public, private, college, foundation, non-profit, ESOP and mutual fund boards, and currently sits on the boards of Blumont Inc., TetraGenetics Inc., the IWF Leadership Foundation and Boston Children’s Hospital. Alison has served as President and CEO of several public and private biotechnology companies (Mitotix, Cambridge Biotech Corporation, Aquila Biopharmaceuticals) and held senior executive positions at Biogen and Genzyme.

In addition, Alison is a member of the Business Advisory Council, Simmons College, School of Management, and of Boston University School of Public Health, Health Law, Policy & Management Advisory Board, a former Director and Chair of MassBio, and of the Biotechnology Innovation Organization (BIO), a Director Emeritus of the Biomedical Science Careers Program, a past Director of the Massachusetts Women’s Forum. In 2005 she was appointed by the Governor to the Massachusetts Biomedical Research Advisory Committee (stem cell research) and in 2008 to the Scientific Advisory Board, Massachusetts Life Science Center.

As an entrepreneur she has successfully founded, built and financed biotechnology companies, including RiboNovix, a company developing antibiotics that are resistant to drug resistance. Her career includes the leadership of teams that discovered, developed and introduced a number of lifesaving drugs, many for diseases that affect children. Today these drugs are used successfully to treat thousands of patients.

Alison is a speaker and teacher in high demand on wide ranging topics involving life sciences, healthcare and healthcare reform. She is active at the state, national and international levels as a representative of her industries, and has testified before federal congressional committees on issues of drug pricing, regulation, bioethics, and cloning. She is an active mentor to women entrepreneurs through a number of organizations including Springboard Enterprises and the International Women’s Forum Leadership Foundation. She also teaches at a number of Boston area universities in postgraduate courses on Ethics, Directors and Boards, the Clinical Development of Biologics, and the Directors Role in Strategy.

Alison attended the University of Bristol in England and the Harvard Business School. She has received a number of awards and honors. In 2002, she was awarded the OBE (Officer of the Order of the British Empire) by Queen Elizabeth II for her work as a leader in the research, development and promotion of biotechnology. In 2009 Alison was awarded a D.Sc. (Honoris Causae) by the University of Bristol.